Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	May 04, 2025	May 05, 2024
OPERATING ACTIVITIES
Net (loss) income	$ (44.8)	$ 151.4
Adjustments to reconcile to net cash used by operating activities:
Depreciation and amortization	67.7	72.1
Equity in net income of unconsolidated affiliates	(10.5)	(13.2)
Deferred taxes	(342.3)	(5.5)
Stock-based compensation expense	12.1	10.5
Impairment of goodwill and other intangible assets	479.5	0.0
Other gain	0.0	(10.0)
Changes in operating assets and liabilities:
Trade receivables, net	21.8	(19.5)
Other receivables	13.6	(0.8)
Inventories, net	(24.3)	69.9
Accounts payable, accrued expenses and deferred revenue	(217.1)	(328.2)
Prepaid expenses	(42.2)	(26.6)
Other, net	15.1	33.2
Net cash used by operating activities	(71.4)	(66.7)
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(26.7)	(38.8)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses	2.5	0.0
Purchases of investments held in rabbi trust	(4.3)	(2.5)
Proceeds from investments held in rabbi trust	0.5	0.1
Net cash used by investing activities	(28.0)	(41.2)
FINANCING ACTIVITIES
Net proceeds from short-term borrowings	115.0	0.0
Repayment of 2022 facilities	(3.0)	(3.0)
Net proceeds from settlement of awards under stock plans	0.1	7.0
Proceeds from 4 1/8% senior notes, net of related fees	0.0	553.1
Redemption of 3 5/8% senior notes	0.0	(561.7)
Cash dividends	(1.9)	(2.2)
Acquisition of treasury shares	(572.2)	(214.0)
Payments of finance lease liabilities	(0.9)	(1.1)
Net cash used by financing activities	(462.9)	(221.9)
Effect of exchange rate on cash and cash equivalents	5.3	(1.6)
Decrease in cash and cash equivalents	(557.0)	(331.4)
Cash and cash equivalents at beginning of period	748.0	707.6
Cash and cash equivalents at end of period	$ 191.0	$ 376.2